Article | Published:

The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice

Abstract

To test whether the hypothesis that the Alzheimer's Aβ peptide is neurotoxic, we introduced a transgene into mice to direct expression of this peptide to neurons. We show that the transgene is expressed in brain regions which are severely affected in Alzheimer's disease resulting in extensive neuronal degeneration. Morphological and biochemical evidence indicates that the eventual death of these cells occurs by apoptosis. Coincident with the cell degeneration and cell death is the presence of a striking reactive gliosis. Over 50% of the transgenic mice die by 12 months of age, half the normal life span of control mice. These data show that Aβ is neurotoxic in vivo and suggest that apoptosis may be responsible for the accompanying neuronal loss, the principal underlying cellular feature of Alzheimer's disease.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Selkoe, D.J. Normal and abnormal biology of the beta-amyloid precursor protein. A. Rev. Neurosci. 17, 489–517 (1994).

  2. 2

    Price, D.L., Borchelt, D.R. & Sisodia, S.S. Alzheimer disease and the prion disorders amyloid β-protein and prion protein amyloidoses. Proc. natn. Acad. Sci. U.S.A. 90, 6381–6384 (1993).

  3. 3

    Glenner, G.G. & Wong, C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. biophys. Res. Commun. 120, 885–890 (1984).

  4. 4

    Masters, C.L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. natn. Acad. Sci. U.S.A. 82, 4245–4249 (1985).

  5. 5

    Kang, J. et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733–736 (1987).

  6. 6

    Ponte, P. et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331, 525–527 (1988).

  7. 7

    Tanzi, R.E. et al. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331, 528–530 (1988).

  8. 8

    Haass, C. et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322–325 (1992).

  9. 9

    Shoji, M. et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126–129 (1992).

  10. 10

    Busciglio, J., Gabuzda, D.H., Matsudaira, P. & Yankner, B.A. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. natn. Acad. Sci. U.S.A. 90, 2092–2096 (1993).

  11. 11

    Seubert, P. et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325–327 (1992).

  12. 12

    Citron, M. et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672–674 (1992).

  13. 13

    Cai, X.-D., Golde, T.E. & Younkin, S.G. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514–516 (1993).

  14. 14

    Cotman, C.W., Pike, C.J. & Copani, A. β-amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol. Aging 13, 587–590 (1992).

  15. 15

    Price, D.L., Borocheit, D.R., Walker, L.C. & Sisodia, S.S. Toxicity of synthetic Aβ peptides and modeling of Alzheimer's disease. Neurobiol. Aging 13, 623–625 (1992).

  16. 16

    Wirak, D.O. et al. Deposits of amyloid β protein in the central nervous system of transgenic mice. Science 253, 323–325 (1991).

  17. 17

    Jucker, M. et al. Age-associated inclusions in normal and transgenic mouse brain. Science 255, 1443–1445 (1992).

  18. 18

    Wirak, D.O. et al. Age-associated inclusions in normal and transgenic mouse brain. Science 255, 1445 (1992).

  19. 19

    Kawabata, S., Higgins, G.A. & Gordon, J.W. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein. Nature 354, 476–478 (1991).

  20. 20

    Sandhu, F.A., Salim, M. & Zain, S.B. Expression of the human β-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice. J. biol. Chem. 266, 21331–21334 (1991).

  21. 21

    Kawabata, S., Higgins, G.A. & Gordon, J.W. Alzheimer's retraction. Nature 356, 23 (1992).

  22. 22

    Kammesheidt, A. et al. Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc. natn. Acad. Sci. U.S.A. 89, 10857–10861 (1992).

  23. 23

    Quon, D. et al. Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352, 239–241 (1991).

  24. 24

    Yamaguchi, F. et al. Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. NeuroReport 2, 781–784 (1991).

  25. 25

    Lamb, B.T. et al. Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet. 5, 22–30 (1993).

  26. 26

    Pearson, B. & Choi, T. Expression of the human β-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. Proc. natn. Acad. Sci. U.S.A. 90, 10578–10582 (1993).

  27. 27

    Wertkin, A.M. et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc. natn. Acad. Sci. U.S.A. 90, 9513–9517 (1993).

  28. 28

    Grundke-Iqbal, I. et al. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 86, 2853–2857 (1989).

  29. 29

    Perry, G., Cras, P., Siedlak, S.L., Tabaton, M. & Kawai, M. β protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am. J. Path. 140, 283–290 (1992).

  30. 30

    Murphy, G.M. et al. Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am. J. Path. 144, 1082–1088 (1994).

  31. 31

    Maruyama, K., Terakado, K., Usami, M. & Yoshikawa, K. Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor. Nature 347, 566–569 (1990).

  32. 32

    Hayashi, Y., Kashiwagi, K. & Yoshikawa, K. Protease inhibitors generate cytotoxic fragments from Alzheimer amyloid protein precursor in cDNA-transfected glioma cells. Biochem. Biophys. Res. Commun. 187, 1249–1255 (1992).

  33. 33

    Yoshikawa, K., Aizawa, T. & Hayashi, Y. Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor. Nature 359, 64–67 (1992).

  34. 34

    Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C.L. & Beyreuther, K. Human and rodent sequence analogs of Alzheimer's amyloid βA4 share similar properties and can be solubilized in buffers of pH 7.4. Eur. J. Biochem. 201, 61–69 (1991).

  35. 35

    Fraser, P.E. et al. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer Amyloid β-protein. Biochemistry 31, 10716–10723 (1992).

  36. 36

    Julien, J.-P., Meyer, D., Flavell, D., Hurst, J. & Grosveld, F. Cloning and developmental expression of the murine neurofilament gene family. Molec. Brain Res. 1, 243–250 (1986).

  37. 37

    Hinrichs, S.H., Nerenberg, M., Reynolds, R.K., Khoury, G. & Jay, G. A transgenic mouse model for human neurofibromatosis. Science 237, 1340–1343 (1987).

  38. 38

    Vogel, J., Hinrichs, S.H., Reynolds, R.K., Luciw, P.A. & Jay, G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335, 606–611 (1988).

  39. 39

    Green, J.E., Hinrichs, S.H., Vogel, J. & Jay, G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature 341, 72–74 (1989).

  40. 40

    Kim, C.-M., Koike, K., Saito, I., Miyamura, T. & Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351, 317–320 (1991).

  41. 41

    CDC. Mortality from Alzheimer disease-United States, 1979–1987. MMWR Morb. Mortal. Wkty. Rep. 39, 785–788 (1990).

  42. 42

    Farlow, M. et al. Clinical characteristics in a kindred with early-onset Alzheimer's disease and their linkage to a G→T change at position 2149 of the amyloid precursor protein gene. Neurology 44, 105–111 (1994).

  43. 43

    Risse, S.C. et al. Myoclonus, seizures, and paratonia in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 4, 217–225 (1990).

  44. 44

    Romanelli, M.F., Morris, J.C., Ashkin, K. & Coben, L.A., Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch. Neurol. 47, 847–850 (1990).

  45. 45

    Hauser, W.A., Morris, M.L., Heston, L.L. & Anderson, V.E. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 36, 1226–1230 (1986).

  46. 46

    Begemann, M., Tan, S.-S., Cunningham, B.A. & Edelman, G.M. Expression of chicken liver cell adhesion molecule fusion genes in transgenic mice. Proc. natn. Acad. Sci. U.S.A. 87, 9042–9046 (1990).

  47. 47

    Wyllie, A.H. Cell death. Int. Rev. Cytol. S17, 755–785 (1987).

  48. 48

    Gavrieli, Y., Sherman, Y. & Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J. Cell Biol. 119, 493–501 (1992).

  49. 49

    Cohen, J.J. Apoptosis. Immunol. Today 14, 126–130 (1993).

  50. 50

    Duffy, P., Mayeuz, R. & Kupsky, W., Famillal Alzheimer's disease with myoclonus and ‘spongy change’. Arch. Neurol. 45, 1097–1100 (1988).

  51. 51

    Carson, D.A. & Ribeiro, J.M. Apoptosis and disease. Lancet 341, 1251–1254 (1993).

  52. 52

    Loo, D.T. et al. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. natn. Acad. Sci. U.S.A. 90, 7951–7955 (1993).

  53. 53

    Norton, W.T., Aquino, D.A., Hozumi, I., Chiu, F.-C. & Brosnan, C.F. Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17, 877–885 (1992).

  54. 54

    Delacourte, A. General and dramatic glial reaction in Alzheimer brains. Neurology 40, 33–37 (1990).

  55. 55

    Vijayan, V.K. et al. Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation. Exp. Neurol. 112, 72–78 (1991).

  56. 56

    Frederickson, R.C.A. Astroglia in Alzheimer's disease. Neurobiol. Aging 13, 239–253 (1992).

  57. 57

    Eng, L.F. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8, 203–214 (1985).

  58. 58

    Mucke, L., Oldstone, M.B.A., Morris, J.C. & Nerenberg, M.I. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol. 3, 465–474 (1991).

  59. 59

    Mandybur, T.I. & Chuirazzi, C.C. Astrocytes and the plaques of Alzheimer's disease. Neurology 40, 635–639 (1990).

  60. 60

    Joachim, C.L., Mori, H. & Selkoe, D.J. Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease. Nature 341, 226–230 (1989).

  61. 61

    Byrne, G.W. & Ruddle, F.H. Multiplex gene regulation: A two-tiered approach to transgene regulation in transgenic mice. Proc. natn. Acad. Sci. U. S. A 86, 5473–5477 (1989).

  62. 62

    Julien, J.-P., Beaudet, L., Tretjakoff, I. & Peterson, A. Neurofilament gene expression in transgenic mice. J. Physiol. (Paris) 84, 50–52 (1992).

  63. 63

    Monteiro, M.J., Hoffman, P.J., Gearhart, J.D. & Cleveland, D.W. Expression of NF-L in both neuronal and nonneuronal cells of transgenic mice: increased neurofilament density in axons without affecting caliber. J. Cell Biol. 111, 1543–1557 (1990).

  64. 64

    Pollock, R.A., Jay, G. & Bieberich, C.J. Altering the boundaries of Hox3.1 expression: evidence for antipodal gene expression. Cell 71, 911–923 (1992).

  65. 65

    Selkoe, D.J. et al. Beta-amyloid precursor protein of Alzheimer disease occurs as 110-to 135 kilodalton membrane-associated proteins in neural and nonneural tissues. Proc. natn. Acad. Sci. U.S.A. 85, 7341–7345 (1988).

  66. 66

    Kim, K.S. et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Comm. 2, 121–130 (1988).

  67. 67

    Kozak, M. Bifunctional messenger RNAs in eukaryotes. Cell 44, 283–292 (1986).

  68. 68

    Carswell, S. & Alwine, J.C. Efficiency of utilization of the simian virus 40 late polyadenylatlon site: effects of upstream sequences. Molec. cell. Biol. 9, 4248–4258 (1989).

  69. 69

    Monteiro, M.J. & Cleveland, D.W. Expression of NF-L and NF-M in f ibroblasts reveals coassembly of neurofilament and vimentin subunits. J. Cell Biol. 108, 579–593 (1990).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading